Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Huaiqihuang Granule in Children With Chronic Primary Immune Thrombocytopenia
NCT03201848Phase 4Active, not recruiting
- Sponsor
- Qidong Gaitianli Medicines Co., Ltd.
- Start
- Nov 2017
- Primary completion
- Oct 2023
- Modality
- HM (Herbal Medicine)
- Countries
- 1
01
Overview
A Phase 4 trial of Huaiqihuang in immune thrombocytopenia (ITP), sponsored by Qidong Gaitianli Medicines Co., Ltd.. Started Nov 2017; status: active, not recruiting.
02
Drugs
Huaiqihuang
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on NCT03201848.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03201848.